GRAL Earnings Date: Nov 4, 2026 (Estimated) — GRAIL Inc.
NASDAQ · Healthcare · Diagnostics & Research
Updated
When is GRAL's next earnings date?
GRAIL Inc. (GRAL) is expected to report Q3 2026 earnings on Wednesday, November 4, 2026 at 4:00 PM ET (after market close); the date is an estimate and has not been confirmed by the company. The consensus estimate is EPS of -$2.45 on revenue of $44.2M.
How did GRAL do in its last earnings report?
In its most recent report on Aug 5, 2026 (Q2 2026), GRAIL Inc. posted EPS of -$2.56 versus the -$2.66 estimate, a beat of 2.0%. Revenue was $42.6M against a $42.4M estimate. The stock's 1-day post-earnings move was -14.5%.
How much does GRAL stock move after earnings?
GRAL beat EPS estimates in 4 of its last 5 reported quarters. Over the last 7 reports the stock moved an average of 14.4% (up or down) in the day after earnings.
About GRAIL Inc.
GRAIL, Inc., a commercial-stage healthcare company, provides multi-cancer early detection testing and services in the United States and internationally. It offers Galleri, a cancer screening test for asymptomatic individuals over 50 years of age; and a diagnostic aid for cancer tests to accelerate diagnostic resolution for patients with clinical suspicion of cancer. The company also provides development services, including support for ongoing clinical studies, pilot testing, research, and therapy development. In addition, its precision oncology portfolio consists of n RUO-targeted methylation-based platform that enables applications for disease prognostication, risk stratification, minimal residual disease detection, and recurrence and relapse monitoring. The company was incorporated in 2015 and is headquartered in Menlo Park, California.
Earnings History
| Date | Period | EPS Est. | EPS Act. | Surprise | Revenue | Result | 1D Δ | 1W Δ | 1M Δ |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-05 | Q2 2026 | -2.66 | -2.56 | -1.99% | $42.6M | ✅ Beat | -14.53% | -7.06% | +8.68% |
| 2026-05-05 | Q1 2026 | -2.17 | -2.29 | -5.53% | $39.8M | ❌ Miss | +15.35% | +13.93% | +22.33% |
| 2026-02-19 | Q4 2025 | -2.93 | -2.44 | +16.72% | $43.6M | ✅ Beat | -50.55% | -42.78% | -53.87% |
| 2025-11-12 | Q3 2025 | -3.36 | -2.46 | +26.79% | $36.2M | ✅ Beat | -1.85% | +3.77% | +7.14% |
| 2025-08-12 | Q2 2025 | -3.39 | -3.18 | +6.19% | $35.5M | ✅ Beat | +1.13% | -6.49% | +15.03% |
| 2025-02-20 | Q4 2024 | — | -2.89 | — | $38.3M | — | -14.72% | -17.75% | -36.58% |
| 2024-08-13 | Q2 2024 | — | -5.30 | — | $32.0M | — | -2.84% | +1.39% | -14.46% |
| 2020-09-28 | — | -0.58 | — | — | — | — | — | — |
Showing last 8 quarters.
Revenue by segment & region
By region
Q2 FY26 · $43.3M total
| Segment | Share | Revenue | YoY | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 |
|---|---|---|---|---|---|---|---|
| UNITED STATES | 95.7% | $41.4M | +21.2% | $34.2M | $32.6M | $70.0M | $38.7M |
| Non-US | 4.3% | $1.8M | +58.4% | $1.2M | $3.3M | $1.3M | $1.1M |
Source: company filings via FMP. YoY compares the same fiscal period a year earlier.